Assembling the eClinical Suite: Taking Advantage of the Latest Technology While Avoiding Vendor Lock-Ins

Not all eClinical applications are the same. For one thing, an eTMF, an EDC, and a CTMS all fulfill different functions. Perhaps more importantly, they are all built with varying degrees of complexity. The eTMF and EDC are both relatively simple applications in the IT world. Either can be introduced for a specific study or for a number of studies. If you’re unhappy with your eTMF or EDC applications, you can switch without too much fuss. The CTMS, on the other hand, is highly complex. It is the nerve center of the eClinical suite and is highly integrated with other software. It can be expensive to introduce, and its normal lifespan is more than 13 years. Therefore, once you install a CTMS, you will be committed for well over a decade. That’s why it is so important to choose your CTMS carefully and be armed with the best knowledge in order to do so. Which CTMS concept will be most functional: one where the entire eClinical suite comes from the same vendor or one where individual components are sourced from different vendors?
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Key Catalysts and their Impact on Pharma Markets

pharmaintelligence

Understand important upcoming milestones that will impact the likelihood of drug approval or future sales potential for key therapies during a free webinar from Informa Pharma Intelligence, "Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets". During this important session, experts from the Datamonitor Healthcare team, part of the Commercial Strategy Suite at Pharma Intelligence, presented their insights into what to expect during the last quarter of the year.
Watch Now

The Product Development Superhighway

Business-review-webinars

Pharmaceutical and biotechnology companies value streamlined services from early-phase development to clinical supply services to commercialization. These services not only provide with improved efficiencies, such as the ease of transition from one development phase to the next, but also remove the challenges of dealing with multiple vendors when transitioning into clinical supplies and commercial availability.
Watch Now

Advances in Aseptic Single-Use Fluid Handling and Management

Pall Corporation

Single-use technology has established itself as an integral part of the biomanufacturing process helping to preserve space, increase flexibility, and save money. Thoughtful design for the handling and transfer of sterile liquids is a key consideration when designing single use systems, and advances in equipment such as sterile connectors have facilitated many of these operations. Assuring aseptic connections are reproducible and sterility is maintained during fluid transfer is underpinned by the design, materials of construction, and in-built quality of the connector. In addition, assessing the risk posed by leachables, which are potentially present in the final drug product, is a regulatory requirement of biopharmaceutical manufacturers. Key to understanding the risk posed by leachables from single-use connectors is data based on agreed test methods, such as BPOG, that enables end users to make informed decisions on patient safety.
Watch Now

Path to Smart Manufacturing and Intelligent Development within Industry 4.0 – Building an Integrated Sensing Strategy

Over the years there have been many frames of reference on the use of process analytical technology (PAT) in the commercial manufacturing space including monitoring, closed-loop control, quality control/real-time release, advanced process control, quality by design, Industry 4.0, etc.
Watch Now